Demystifying treatment timelines for KRAS+ NSCLC, the 2022 Targeted Therapies Forum presents Dr. Jia Luo, an esteemed Medical Oncologist from Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard. Dive deep into the intricacies of KRAS Mutated NSCLC management as Dr. Luo meticulously outlines the treatment timelines for patients diagnosed with KRAS+ NSCLC in this enlightening English edition.
A massive shoutout to our revered sponsors who have been instrumental in bringing this knowledge to you: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech.
Expand your horizons in oncological treatments and breakthroughs by visiting http://cancerGRACE.org/. Engage, inquire, and connect with a community of experts and survivors at https://cancergrace.org/forum.